An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of Southern Sweden: The clinical utility of the ACR renal response criteria and predictors for renal outcome

Scandinavian Journal of Rheumatology

Volumn 42, Issue 5, 2013, Pages 383-389

  Nived, O ^a   Hallengren, C S ^a   Alm, P ^b   Jonsen A ^a   Sturfelt, G ^a   Bengtsson, A A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEPHROTIC SYNDROME; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; SLEDAI; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; BIOPSY; CHILD; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROTEINURIA; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; SWEDEN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883729255     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2013.799224     Document Type: Article

References (40)

1. Molino C, Fabbian F, Longhini C. Clinical approach to lupus nephritis: recent advances. Eur J Intern Med 2009;20:447-53.
2. Zabaleta-Lanz ME, Munôz LE, Tapanes FJ, Vargas-Arenas RE, Daboin I, Barrios Y, et al. Further description of early clinically silent lupus nephritis. Lupus 2006;15:845-51.
3. Cross J, Jayne D. Diagnosis and treatment of kidney disease. Best Pract Res Clin Rheumatol 2005;19:785-98.
4. Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol 2006;33:1563-9.
5. Fiehn C, Hajjar Y, Mueller K, Waldherr R, Ho AD, Andrassy K. Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis 2003;62:435-9.
6. McCluskey RT. Lupus nephritis. In: Sommers SC, editor. Kidney pathology decennial, 1966-1975. New York: Appleton-Century-Crofts, 1975:435-50.
7. Churg J, Sobin L. Renal disease, classification and atlas of glomerular diseases. Tokyo/New York: Igaku-Shoin, 1982.
8. Lewis EJ, Schwartz MM, Korbet SM. Severe lupus nephritis: importance of re-evaluating the histological classification and the approach to patient care. J Nephrol 2001;14:223-7.
9. Schwartz MM, Lewis EJ. Rewriting the histological classification of lupus nephritis. J Nephrol 2002;15(Suppl 6):S11-19.
10. Mok CC. Prognostic factors in lupus nephritis. Lupus 2005;14:39-44.
11. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CH, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65:521-30.
12. Furness PN, Taub N. Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis - a UK-wide study. Am J Surg Pathol 2006;30:1030-5.
13. Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, et al. Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis. Nephrol Dial Transplant 2008;23:223-30.
14. Seo J, Do IG, Park ES, Kwon GY, Ko YH. Pathology of lupus nephritis is better classified by the International Society of Nephrology-Renal Pathology Society system. Basic Appl Pathol 2008;1:12-17.
15. Hiramatsu N, Kuroiwa T, Ikeuchi H, Maeschima A, Kaneko Y, Hiromura K, et al. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatology 2008;47:702-7.
16. Markowitz GS, D'Agati VD. Classification of lupus nephritis. Curr Opin Nephrol Hypertens 2009;18:220-5.
17. Yu F, Wu LH, Tan YH, Li LH, Wang CL, Qu Z, et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 2010;77:820-9.
18. Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR. Tubulointerstitial inflammation and scarring predict outcome in lupus nephritis. Arthritis Care Res (Hoboken) 2011;63:865-74.
19. Sada KE, Makino H. Usefulness of ISN/RPS classification of lupus nephritis. J Korean Med Sci 2009;24(Suppl):S7-10.
20. Austin HA, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis. Contribution of renal histological data. Am J Med 1983;75:382-91.
21. Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 1989;72:779-833.
22. Wei CH, Ho YS, Chou BL, Sheu LF, Shieh SD, Chen A, Tu YC. Lupus nephritis, emphasizing tubulointerstitial lesions: a clinicopathological analysis. Zhonghua Yi Xue Za Zhi (Taipei) 1993;51:27-32.
23. Danila MI, Pons-Estel GJ, Zhang J, Vila LM, Reveille JD, Alarcon GS. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology (Oxford) 2009;48:542-5.
24. Liang H, Schur PH, Fortin P, St Clair EW, Costenbader K, Crofford L, et al. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006;54:421-32.
25. Staahl-Hallengren C, Jonsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000;27:685-91.
26. Tan E, Cohen A, Fries J, Masi A, McShane D, Rothfield N, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
27. Krutzen E, Bäck SE, Nilsson-Ehle I, Nilsson-Ehle P. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med 1984;104:955-61.
28. Sterner G, Frennby B, Maansson S, Nyman U, Van Westen D, Almen T. Determining 'true' glomerular filtration rate in healthy adults using infusion of inulin and comparing it with values obtained using other clearance techniques or prediction equations. Scand J Nephrol 2008;42:278-85.
29. Vervoort G, Willems HL, Wetzels JF. Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant 2002;17:1909-13.
30. Nyman U, Grubb A, Sterner G, Björk J. The CKD-EPI and MDRD equations to estimate GFR. Validation in the Swedish Lund-Malmö Study cohort. Scand J Clin Lab Invest 2011;71:129-38.
31. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288-91.
32. Cottiero RA, Madaio MP, Levey AS. Glomerular filtration rate and urinary albumin excretion rate in systemic lupus erythematosus. Nephron 1995;69:140-6.
33. Tencer J, Thysell H, Grubb A. Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin. Scand J Clin Lab Invest 1996;56:691-700.
34. Ng WY, Lui KF, Thai AC. Evaluation of a rapid screening test for microalbuminuria with a measurement of urine albumin-creatinine ratio. Ann Acad Med Singapore 2000;29:62-5.
35. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47.
36. Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiano GD, de Ramon Garrido E, Danieli MG, et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis. Lessons from long-term follow up of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum 2004;50:3934-40.
37. Sturfelt G, Truedsson L. Complement in the immunopathogenesis of rheumatic disease. Nat Rev Rheumatol 2012;8:458-68.
38. Petri M, Kasitanon N, Lee SS, Link K, Magder L, Bae SC, et al. Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum 2008;58: 1784-8.
39. Petri M, Kasitanon N, Singh S, Link K, Magder L, Bae SC, et al. Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum 2008;58:1789-95.
40. Yee CS, Gordon C, Dostal C, Petera P, Dadoniene J, Griffiths B, et al. EULAR trial of pulse cyclophosphamide versus continuous cyclophosphamide followed by azathioprine in lupus nephritis. Ann Rheum Dis 2004;63:525-9.